Portland immunotherapy startup tops $10M in funding as it launches first clinical trial – GeekWire
GeekWire |
Portland immunotherapy startup tops $10M in funding as it launches first clinical trial
GeekWire The new money will fund the first clinical trial of Veana's lead drug candidate, Vimo — a derivative of vitamin E that could make cutting-edge cancer immunotherapy drugs more effective, without the toxic side effects of chemo. Akporiaye said that Vimo … |
